HDRP.F Stock Overview
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Epsilon Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.0014 |
| 52 Week High | AU$0.0014 |
| 52 Week Low | AU$0.0014 |
| Beta | 0.92 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | -99.56% |
| Change since IPO | -99.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| HDRP.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -3.4% | -1.2% |
| 1Y | n/a | 17.1% | 30.6% |
Return vs Industry: Insufficient data to determine how HDRP.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how HDRP.F performed against the US Market.
Price Volatility
| HDRP.F volatility | |
|---|---|
| HDRP.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: HDRP.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HDRP.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Daniel Sanghera | epsilonhealthcare.com.au |
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021.
Epsilon Healthcare Limited Fundamentals Summary
| HDRP.F fundamental statistics | |
|---|---|
| Market cap | US$4.76m |
| Earnings (TTM) | -US$5.93m |
| Revenue (TTM) | US$7.21m |
0.0x
P/S Ratio0.0x
P/E RatioIs HDRP.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HDRP.F income statement (TTM) | |
|---|---|
| Revenue | AU$7.21m |
| Cost of Revenue | AU$5.09m |
| Gross Profit | AU$2.12m |
| Other Expenses | AU$8.05m |
| Earnings | -AU$5.93m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.02 |
| Gross Margin | 29.46% |
| Net Profit Margin | -82.17% |
| Debt/Equity Ratio | 27.1% |
How did HDRP.F perform over the long term?
See historical performance and comparison